Policy & Regulation
Fluxergy partners with Mass General Brigham to begin evaluation of one hour COVID-19 diagnostic test results
3 July 2020 - Fluxergy said on Thursday that it will further evaluate its Research Use Only (RUO) COVID-19 testing platform designed to deliver accurate PCR test results in under one hour in partnersh...
BrainStorm Cell Therapeutics doses final participant in NurOwn phase three pivotal trial
3 July 2020 - BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI), a United States-based biotechnology company, has dosed its final participant in the phase three pivotal trial of NurOwn (MSC-NTF cells) i...
Fluxergy and MGB collaborate to assess Fluxergy's Research Use Only COVID-19 testing platform
3 July 2020 - United States-based Fluxergy and Mass General Brigham (MGB), a medical institution, are collaborating to further assess Fluxergy's Research Use Only COVID-19 testing platform, it wa...
Theravance Biopharma names new director
3 July 2020 - Theravance Biopharma Inc (NASDAQ: TBPH), a Cayman Islands-based biopharmaceutical company, has named Deepika R Pakianathan, PhD as its new director, it was reported on Thursday.Dr Pakian...
Cancer Prevention Pharmaceuticals Submits New Drug Application to the FDA for CPP-1X/sul for Treatment of Familial Adenomatous Polyposis
2 July 2020 - - US-based biotechnology company Cancer Prevention Pharmaceuticals, Inc has submitted a New Drug Application to the US Food and Drug Administration seeking accelerated approval for CPP-1...
Menarini Ricerche Plans to Launch C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer
2 July 2020 - - Italy-based Menarini Ricerche, the R and D division of pharmaceutical and diagnostics company the Menarini Group, plans to launch in the second-half of 2020 a new phase Ib/II trial of ...